Krista M. Dalton

Catastrophic ATP loss underlies a metabolic combination therapy tailored for <i>MYCN</i> -amplified neuroblastoma

Krista M. Dalton, Timothy L. Lochmann, Konstantinos V. Floros et al. · Proceedings of the National Academy of Sciences · 2021 · 23 citations · Full text

Medicine, Cancer Biology, Oncology +17

Venetoclax-based Rational Combinations are Effective in Models of <i>MYCN</i> -amplified Neuroblastoma

Krista M. Dalton, Kateryna Krytska, Timothy L. Lochmann et al. · Molecular Cancer Therapeutics · 2021 · 19 citations · Full text

Medicine, Oncology, Pharmacology +13

High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition

Jinyang Cai, Sheeba Jacob, Richard Kurupi et al. · Cell Reports · 2022 · 18 citations · Full text

Medicine, Cancer Biology, Oncology +17

Targeting Oncogenic Mutant p53 and BCL-2 for Small Cell Lung Cancer Treatment

Victoria Neely, Alekhya Manchikalapudi, Khanh Nguyen et al. · International Journal of Molecular Sciences · 2023 · 11 citations · Full text

Medicine, Oncology, Pharmacology +15